Synthetic Vaccine for the Treatment of Lesions Caused by High Risk Human Papilloma Virus

Author(s):
Melief, C.J.M.
Published
2011
Publication type
Article / Letter to editor
Human papilloma virus type 16 (HPV16)cancer vaccinesynthetic vaccinepeptide vaccineT-lymphocyteCD4 T-cell CD8 T-cellvulvar intraepithelial neoplasia (VIN)Montanide ISA-51
Date issued
2011-10-31
Language
English
Is part of
Cancer Journal (2011), Vol. 17, no. 5, p. 300-301
hdl
1887/111117
doi
10.1097/PPO.0b013e318235e0fe